EverHint – Momentum Swing — Explosive Volume Breakout for Feb 24, 2026 – 7 Signals – Healthcare Leads (3)

What This Signal Is (Quick)

Explosive Volume Breakout is a momentum swing trading strategy focused on Breakouts with 2.5x+ volume surge - institutional buying pressure.

Signal Type: Breakout (momentum continuation)

What Makes This Signal:

• Stock showing strong momentum near or at highs
• Increased volume confirms institutional interest
• Breaking out or consolidating near resistance
• Breakouts with 2.5x+ volume surge - institutional buying pressure

Ideal For: Traders seeking breakouts with exceptional volume confirmation

Key Criteria:

• Strong RSI momentum (configurable thresholds)

• Volume surge above average

• Price momentum confirmation

• Minimum ADV: $25M+ (varies by variant)

• Earnings buffer: 7 days pre/post earnings

• Variant-specific filters applied

Holding Period: 1-4 weeks
Risk Level: Medium-High

How We Ranked Today

Ranked by composite momentum score (higher = stronger momentum)

📊 Momentum Swing — Explosive Volume Breakout Signals (7 Total)

Ranked by score:

Field Notes

Sector concentration: Healthcare (3), Technology (2), Real Estate (1)

Insider selling: KEYS (Keysight Technologies Inc., $-15.4M), VVX (V2X, Inc., $-66.1M), VIR (Vir Biotechnology, Inc., $-132K)

Data coverage: 42.9% insider, 0.0% congressional, 100.0% earnings, 100.0% analyst, 57.1% news

Peer Analysis

Understanding how these stocks relate to their industry peers:

HSIC (Henry Schein, Inc.): Leads 9 peers: GMED ($91.92, -1.6%), ATR ($144.14, -1.1%), GRFS ($9.07), MOH ($148.31, -5.1%), HALO ($70.36, -0.4%) | Peer of: ATR ($144.14, -1.1%), AVTR ($9.11, +2.5%), BIO ($268.70, +0.2%) and 9 more

VIR (Vir Biotechnology, Inc.): Leads 9 peers: MRVI ($3.12, +2.0%), IOVA ($3.78, +30.8%), REPL ($8.36, -0.4%), PRME ($3.83, +14.7%), DNA ($8.86) | Peer of: CDNA ($19.25, +2.5%), CSTL ($29.94, +3.5%), DAWN ($12.02, +2.7%) and 11 more

KEYS (Keysight Technologies Inc.): Leads 9 peers: CLS ($296.35, -0.1%), HPE ($20.25, +1.2%), TER ($329.09, +3.3%), TDY ($683.22, +1.6%), JBL ($266.26, +1.9%) | Peer of: ALAB ($128.40, +0.1%), CLS ($296.35, -0.1%), CRDO ($120.83, -2.6%) and 9 more

VVX (V2X, Inc.): Leads 7 peers: CDRE ($42.15, -0.2%), HNI ($48.57, -1.0%), CECO ($60.00, -22.8%), PBI ($10.63, +2.4%), DXPE ($159.37, +5.8%) | Peer of: ARLO ($11.61, +1.7%), ATRO ($79.39, +4.0%), CDRE ($42.15, -0.2%) and 9 more

SUPN (Supernus Pharmaceuticals, Inc.): Leads 10 peers: HCM ($15.08, -0.6%), PRGO ($14.61, +0.4%), XENE ($44.79, +4.8%), INDV ($33.06, +0.4%), BHC ($6.02, +0.7%) | Peer of: AMRX ($14.66, +1.7%), HCM ($15.08, -0.6%), INDV ($33.06, +0.4%) and 4 more

UCTT (Ultra Clean Holdings, Inc.): Leads 9 peers: MXL ($18.25, +1.7%), COHU ($30.60, +0.6%), INDI ($3.53, +2.6%), FSLY ($17.67, +3.9%), PLAB ($37.99, +2.6%) | Peer of: AAOI ($56.27, +4.3%), AMPL ($6.83, +5.1%), COHU ($30.60, +0.6%) and 6 more

VRE (Veris Residential, Inc.): Leads 9 peers: LADR ($10.30, -0.6%), TRTX ($8.36, +0.2%), UMH ($16.19, -0.1%), EFC ($12.46, +0.4%), ARI ($10.64, +1.8%) | Peer of: FOR ($29.09, -1.5%), IIPR ($51.10, +10.7%), SILA ($25.51, -0.3%) and 2 more

Recent Headlines

KEYS (Keysight Technologies Inc.)

• Keysight Q1 Earnings Beat Estimates on Healthy Top-Line Growth (source)
• Keysight Technologies Inc (KEYS) Q1 2026 Earnings Call Highlights: Record Revenue and Strong Growth Across Segments (source)
• Keysight Technologies Proves To Be An AI Winner (source)
• Keysight Technologies, Inc. (KEYS) Q1 2026 Earnings Call Transcript (source)
• Keysight (KEYS) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates (source)
• Keysight (KEYS) Beats Q1 Earnings and Revenue Estimates (source)
• Market Today: Tariffs, AI Jitters; LLY, MRK, WBD in Focus (source)
• Keysight Stock Rallies After Q1 Earnings Beat Estimates (source)
• Keysight forecasts quarterly profit above estimates on strong data center-led demand (source)
• Keysight Technologies Reports First Quarter 2026 Results (source)
• Keysight (KEYS) Is Up 4.30% in One Week: What You Should Know (source)
• Stock Market Today: Dow Jones, S&P 500 Futures Drop After Supreme Court Strikes Down Trump's Emergency Tariffs— Novo Nordisk, Strategy, Vanda In Focus (source)
• Keysight Introduces Infiniium XR8 Oscilloscopes to Accelerate High-Speed Digital Validation and Compliance (source)
• KEYS Set to Report Q1 Results: Will Revenue Growth Boost Earnings? (source)
• Keysight Introduces Scale-Up Validation Solutions for AI Data Centers (source)
• Unlocking Q1 Potential of Keysight (KEYS): Exploring Wall Street Estimates for Key Metrics (source)
• Keysight Introduces PAM3 Signaling with New GDDR7 Transmitter Compliance Solution for Next-Generation Graphics Memory (source)
• Keysight Unveils 3D Interconnect Designer for Chiplet and 3DIC Advanced Package Designs (source)
• Spirent Introduces First Domain-Trained Agentic AI Solution for Network Testing and Assurance (source)

VIR (Vir Biotechnology, Inc.)

• Vir Biotechnology Announces Proposed Public Offering of Common Stock (source)
• Vir Biotechnology: Up On Prostate Data And Astellas Deal - I'm (Long-Term) Bullish (source)
• These Analysts Boost Their Forecasts On Vir Biotechnology (source)
• Stock Market Today: S&P 500 Futures Slip As Dow, Nasdaq 100 Gain Following Trump's Tariff Threat — Whirlpool, Uber, HP In Focus (UPDATED) (source)
• What's Happening With VIR Stock? (source)
• Vir Biotechnology, Inc. (VIR) Q4 2025 Earnings Call Transcript (source)
• Vir Biotechnology, Inc. (VIR) Reports Q4 Loss, Beats Revenue Estimates (source)
• Vir Biotech Catapults 65% On A $1.71 Billion Deal With Astellas (source)
• Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results (source)
• Vir Biotechnology Reports Positive Updated Phase 1 Results for PSMA-targeting, PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 in Patients with Metastatic Prostate Cancer (source)
• Astellas and Vir Biotechnology Announce Global Strategic Collaboration to Advance PSMA-targeting PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 for the Treatment of Prostate Cancer (source)

VRE (Veris Residential, Inc.)

• Veris Residential Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Veris Residential, Inc. - VRE (source)
• Veris Residential Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Veris Residential, Inc. - VRE (source)
• Are ACLX, VRE, UHG, EHAB Obtaining Fair Deals for their Shareholders? (source)
• Are ACLX, VRE, UHG, EHAB Obtaining Fair Deals for their Shareholders? (source)
• $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Veris Residential, Inc. (NYSE: VRE) (source)
• $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Veris Residential, Inc. (NYSE: VRE) (source)
• Veris (VRE) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (source)
• Veris (VRE) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (source)
• Veris Residential (VRE) Q4 FFO and Revenues Top Estimates (source)
• Veris Residential (VRE) Q4 FFO and Revenues Top Estimates (source)
• Shareholder Alert: The Ademi Firm investigates whether Veris Residential Inc. is obtaining a Fair Price for its Public Shareholders (source)
• Shareholder Alert: The Ademi Firm investigates whether Veris Residential Inc. is obtaining a Fair Price for its Public Shareholders (source)
• VRE Stock Alert: Halper Sadeh LLC is Investigating Whether Veris Residential, Inc. is Obtaining a Fair Price for its Shareholders (source)
• VRE Stock Alert: Halper Sadeh LLC is Investigating Whether Veris Residential, Inc. is Obtaining a Fair Price for its Shareholders (source)
• Veris Residential to Be Acquired by Affinius Capital-Led Investor Consortium for $3.4 Billion in Cash (source)
• Veris Residential to Be Acquired by Affinius Capital-Led Investor Consortium for $3.4 Billion in Cash (source)
• Veris Residential, Inc. Reports Fourth Quarter and Full Year 2025 Results (source)
• Veris Residential, Inc. Reports Fourth Quarter and Full Year 2025 Results (source)
• $17 Million Bet on Veris Residential Stock: What a 1.2 Million Share Buy Signals to Investors Now (source)
• $17 Million Bet on Veris Residential Stock: What a 1.2 Million Share Buy Signals to Investors Now (source)

VVX (V2X, Inc.)

• Don't Overlook These Top Stocks After Q4 EPS Beats: ALSN, BWXT, VIV, VVX (source)
• V2X Q4 Earnings Call Highlights (source)
• V2X, Inc. (VVX) Q4 2025 Earnings Call Transcript (source)
• V2X (VVX) Tops Q4 Earnings and Revenue Estimates (source)
• V2X Reports Fourth Quarter 2025 Results (source)
• AI Takes Flight: Five Companies Advancing Defense and Aerospace Intelligence (source)
• V2X Awarded ATSP5 Contract to Advance Emerging Technology for the Warfighter (source)

Market Context

Broad market indices advanced today, with the S&P 500 up 0.77%, Nasdaq gaining 0.98%, and Dow Jones rising 0.71%, signaling a risk-on environment conducive to momentum strategies. The VIX dropped sharply by 7.91% to 19.56, reflecting reduced volatility and a calmer trading atmosphere. For momentum swing explosive volume breakout signals, this lower volatility tempers extreme intraday swings, potentially leading to more reliable breakouts on sustained volume rather than whipsaw moves, though it may compress profit margins compared to higher-volatility regimes.

Upward trends across major indices underscore positive momentum and healthy risk appetite, favoring breakout strategies that capture explosive volume surges in the short term. With all benchmarks posting gains, the market's bullish bias supports swing trades aiming to ride intraday or multi-day continuations, but traders should monitor for any reversal cues as elevated VIX levels earlier hinted at lingering caution.

Healthcare emerging as the top sector amid broad gains suggests subtle rotation toward resilient areas, bolstering the 7 total signals under this strategy. Lower volatility enhances the odds of clean breakouts in leading sectors like Healthcare, where volume spikes can signal sustained swings without broad market turbulence disrupting momentum.

Vlad's Take (EverHint)

Today's signals: Strong sector concentration in Healthcare (3 signals) suggests sector-specific rotation. 3 signals showing insider selling warrant caution.

Sharing Call-to-Action

🌟 Help the channel grow: like, share, or subscribe if you find value in what EverHint publishes.

Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

This is not financial advice. Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/